 |
Video: What is a Stock Split?
|
 |
60 Degrees Pharmaceuticals is a pharmaceutical company focused on using biological science and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases. Co. has received regulatory approval of Arakoda, a malaria preventative treatment that is on the market. Co.'s pipeline under development covers development programs for COVID-19, fungal, tick-borne, and other viral diseases through Arakoda and Celgosivir. According to our SXTP split history records, 60 Degrees Pharmaceuticals has had 2 splits. | |
 |

60 Degrees Pharmaceuticals (SXTP) has 2 splits in our SXTP split history database. The first split for SXTP took place on August 12, 2024. This was a 1 for 12 reverse split, meaning for each 12 shares of SXTP owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 83.3333333333333 share position following the split. SXTP's second split took place on February 24, 2025. This was a 1 for 5 reverse split, meaning for each 5 shares of SXTP owned pre-split, the shareholder now owned 1 share. For example, a 83.3333333333333 share position pre-split, became a 16.6666666666667 share position following the split.
When a company such as 60 Degrees Pharmaceuticals conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the SXTP split history from start to finish, an original position size of 1000 shares would have turned into 16.6666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into 60 Degrees Pharmaceuticals shares, starting with a $10,000 purchase of SXTP, presented on a split-history-adjusted basis factoring in the complete SXTP split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
07/13/2023 |
|
End date: |
04/29/2025 |
|
Start price/share: |
$271.80 |
|
End price/share: |
$2.55 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.06% |
|
Average Annual Total Return: |
-92.56% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$93.74 |
|
Years: |
1.80 |
|
|
 |
Date |
Ratio |
08/12/2024 | 1 for 12 | 02/24/2025 | 1 for 5 |
|
 |